SAN DIEGO, Sept. 28, 2015 /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that William A. Roper, Jr. has been appointed Chief Financial Officer, reporting directly to HLI's CEO, J. Craig Venter, Ph.D. Roper joins the company full-time after serving as interim CFO.
Roper has significant leadership experience in operational and financial management, mergers and acquisitions, capital raising, and strategic restructurings across a broad spectrum of industries and markets. He has also served on the boards of several public and private companies, serving as Lead Independent Director and Chair of the Audit, Compensation, and Finance Committees.
Roper has held a number of executive positions throughout his career, such as 17 years as Executive Vice President of SAIC, Inc., a diversified science and technology services organization, whose annual revenues grew from less than $1 Billion to nearly $9 Billion during his seventeen years with the company.
He also served as President and CEO of Verisign, Inc., the leading global provider of internet infrastructure and security services and a member of the NASDAQ 100, where he was responsible for restructuring and repositioning the company.
"Bill brings a demonstrated track record of success navigating rapidly changing environments at the helm of both publicly-traded and privately-owned companies. His strategic business mind and marketplace savvy have already proven valuable to our HLI team, and we're thrilled he's agreed to join us full-time," said J. Craig Venter, Ph.D., Co-founder and CEO, HLI.
Roper holds a BA in Mathematics from the University of Mississippi and graduated from the Southwestern Graduate School of Banking at Southern Methodist University. He also completed the Financial Management Program at Stanford University.
HLI is also pleased to announce the promotion of Viktoria Brough to Vice President of Finance, Controller, reporting to Bill Roper. Brough has been instrumental in leading the build out of the HLI Finance organization. She joined the company in 2014 after spending over ten years as an auditor at Ernst & Young Assurance practice in San Diego.
About Human Longevity, Inc.
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. A privately held company headquartered in San Diego, CA, HLI was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visit, http://www.humanlongevity.com/.
SOURCE Human Longevity, Inc.